![](https://www.diabetesnews.com/wp-content/uploads/2013/07/pills-150x150.jpg)
A new clinical trial is testing a study drug that could help the T2D community eliminate a daily injection:
Key Inclusion / Exclusion Criteria:
– Are between 18 and 80 years old
– Have a diagnosis of type 2 diabetes
– Are taking both metformin and liraglutide (Victoza)
– Have a BMI (body mass index) between 25 and 45
– Have not had weight loss surgery